What LEK Consulting does

L.E.K. Consulting is a global strategy consulting firm founded in 1983 by James L. Lawrence and headquartered in Boston, Massachusetts (legal entity L.E.K. Consulting LLC). The firm operates as a private partnership with 2,300+ professionals across 27 offices in the Americas, EMEA, Asia-Pacific, and the Middle East, led by Global Managing Partner Clay Heskett (elected to a second term). L.E.K. serves enterprise and private equity clients across core sectors—life sciences and pharma, healthcare services, medtech, consumer, financial services, industrials, and private equity—supporting an estimated 1,000+ transactions annually and 1,200+ corporate projects.

The firm's core methodology is built around the trademarked Edge Strategy® framework, full-lifecycle M&A services (from target identification through post-merger integration), and proprietary analytics assets including the Biomedical Intelligence Lab (BIL). BIL combines real-world data, combinatorial scenario modeling, and simulation-based valuation, and has been credited with achieving 90%+ accuracy in COVID-19 forecasting. L.E.K. has also invested in AI/Data and Analytics capabilities, including AI Strategy and AI-First Operating Model practices, with AI modalities spanning structured data, text, and multimodal inputs across predictive analytics, knowledge retrieval, process automation, generative AI, and optimization use cases.

The business model is senior-partner-led project-based consulting with customary time-and-materials or fixed-fee engagement structures. The firm is enterprise-only in its go-to-market, with deep, recurring relationships in private equity and large corporates. Capability expansion is executed via organic practice build-out, lateral senior hires (e.g., Christian Boettcher, Koya Tsukiji, Michael Retterath, Paul Mountney, Tim Ogonoski), and inorganic moves such as the January 2023 acquisition of digital transformation consultancy Hi Mum! Said Dad (HMSD). Recent geographic moves include new Dubai and Manama offices (December 2024), and ecosystem partnerships include a digital health commercialization alliance with ANDHealth (April 2026).

Name

LEK Consulting

Legal name

L.E.K. Consulting LLC

Website

https://lek.com

Company type

Private

Founded year

1983

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

L.E.K. Consulting is a global strategy consulting firm with 2,300+ professionals across 27 offices, serving enterprise and private equity clients in life sciences, healthcare, consumer, industrials, and private equity through senior-partner-led engagements and proprietary analytics like the Biomedical Intelligence Lab.

Ownership category

akta.pro rank

Product category

Management Consulting Services

NAICS

Management Consulting Services (54161), Administrative Management and General Management Consulting Services (541611), Management, Scientific, and Technical Consulting Services (5416), Marketing Consulting Services (541613)

SIC

Services-Management Consulting Services (8742), Services-Engineering, Accounting, Research, Management (8700)

akta.pro primary industry

Strategy & Corporate Development Consulting (BPAHACAA)

akta.pro secondary industries

Corporate Strategy Advisory (BPAHADAA), M&A Advisory (Buy-Side & Sell-Side) (BPAHAOAA), Operations & Process Improvement Consulting (BPAHACAB), Customer, Marketing & Sales Consulting (BPAHACAG), Financial Management & Performance Improvement Consulting (BPAHACAF)

Keywords

• Strategy consulting
• Management consulting
• Mergers acquisitions advisory
• Private equity consulting
• Life sciences consulting

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices15 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Strategy Consulting Fees: L.E.K. Consulting generates revenue through professional consulting fees charged for strategic advisory engagements. Fees are structured on a project-by-project basis or as retainer arrangements, typically serving enterprise clients on high-stakes strategic decisions including M&A transactions, growth strategy, performance improvement, and organizational transformation.

Pricing tiers

Go-to-market motion2 records

Distribution channels1 record

Marketing channels8 records

Core offering

L.E.K. Consulting is a global management consulting firm that sells strategic advisory services to corporations, private equity sponsors, and healthcare organizations. Engagements span growth strategy, mergers and acquisitions support, commercial due diligence, pricing and revenue optimization, performance improvement, digital and AI strategy, and sector-specific advisory across life sciences, healthcare, consumer, financial services, and industrials, delivered by senior partners using proprietary frameworks and analytics.

Product overview

L.E.K. Consulting is a global strategy consulting firm offering a comprehensive portfolio of advisory services rather than a unified software product. The firm operates across multiple service practice areas (Artificial Intelligence, Data & Analytics, Digital, M&A, Operations & Supply Chain, Performance Improvement, Pricing & Revenue Optimization, Private Equity, Strategy, Sustainability) and industry verticals (Life Sciences & Pharma, Healthcare Services, MedTech, Consumer Products, Financial Services, Industrials including Paper & Packaging, Retail, Technology, Media & Entertainment, and Travel/Transport/Logistics). Key specialized offerings include the Biomedical Intelligence Lab (BIL) for life sciences analytics, the proprietary Edge Strategy® methodology, and dedicated AI capabilities spanning strategy development, solution deployment, and AI-first operating model adoption. The firm supports clients through the full deal lifecycle and across operational transformation needs.

Differentiator

Problem solved

Functional benefit

Brands

• Biomedical Intelligence Lab (BIL): A focused group within the Life Sciences practice that leverages data-driven approaches and advanced analytics for biomedical science decision-making
• Edge Strategy®

Products and services

• Artificial Intelligence Services Comprehensive AI consulting offerings including AI strategy development, data strategy, AI solution development and deployment, and operating model adoption support. Targeted at organizations integrating AI into their operations and decision-making.
• Data & Analytics Services Advanced analytics consulting including Advanced Analytics Strategy to help organizations leverage data assets for strategic decision-making. Targeted at organizations seeking to operationalize analytics.
• Mergers & Acquisitions Services Full M&A lifecycle support from target identification and due diligence through post-merger integration and synergies realization. Serves corporates and private equity clients executing buy-side and sell-side transactions.
• Pricing & Revenue Optimization Services Specialized pricing consulting across multiple sectors including SaaS, Consumer, Healthcare Services, Industrials B2B, Media & Entertainment, Medtech, and Pharmaceutical Pricing and Market Access. Aimed at companies seeking to optimize pricing, capture, and customer value.
• Performance Improvement Services Operational excellence services including Dynamic Performance Management, Cost Optimization, and Working Capital. Targeted at organizations pursuing margin expansion and operational efficiency.
• Life Sciences & Pharma Consulting Comprehensive consulting for biotech, pharmaceuticals, pharma services, diagnostics, drug delivery, and biomedical intelligence from R&D through commercial stages. Serves life sciences and pharmaceutical clients globally.
• MedTech Consulting Consulting services for medical technology companies covering consumables and disposables, medical equipment, and procedure-specific devices. Supports market access, commercial excellence, and go-to-market strategy.
• Healthcare Services Consulting Advisory services for health plans, hospitals and acute care providers, physician practices, post-acute care, home health, diagnostics, healthcare IT, supply chain, and digital health organizations. Focused on financial performance and digital transformation.
• Paper & Packaging Consulting Global advisor to the packaging sector offering M&A support, growth strategy, post-merger integration, and operational improvement services across the packaging value chain. Serves converters, packaging manufacturers, and packaging-using brands.
• Private Equity Consulting Specialized consulting for private equity sponsors including Commercial Due Diligence, Portfolio Company Value Enhancement, and Vendor Due Diligence. Supports investment decisions and value creation across the PE deal lifecycle.
• Biomedical Intelligence Lab (BIL) A focused analytics group within the Life Sciences practice delivering advanced analytics, bioinformatics, and AI-powered modeling for biotech capital allocation, pipeline prioritization, trial design, and launch planning. Targets life sciences organizations evaluating drug, pipeline, and market opportunities.
• Edge Strategy® Consulting L.E.K.'s proprietary strategic framework (registered trademark) that helps clients identify and capitalize on small shifts in positioning or approach that create disproportionate value. Applied across strategy engagements.
• Strategy Consulting Services Strategy consulting covering business unit strategy, corporate strategy, growth strategy, new product strategy, and Edge Strategy® methodology. Serves executive leadership at large corporates.

Quantifiable outcome

• Over 90% accuracy in short-term COVID-19 demand forecasts across all major markets for a leading biopharma client
• +4 more outcomes

Named customers9 records

Segments8 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability8 records

Feature6 records

Partnerships

Five partnerships are on record, tiered minor and core.

• MedSpeedminorStrategic or Co-development Partner · 2 June 2026L.E.K. Consulting and MedSpeed co-authored a report highlighting that preventable last-mile logistics errors are costing U.S. health systems millions annually and jeopardize patient care. The report underscores that mishandled lab specimens, pharmaceuticals, and surgical supplies cause significant financial and safety risks, advocating for health systems to improve logistics providers to enhance care and reduce costs.
• Saltus Partnership ProgrammeminorStrategic or Co-development Partner · 28 May 2026Saltus Partnership Programme and L.E.K. Consulting co-authored research finding that 42% of financial planning firms are using technology investment to manage growth and regulatory demands, up from 35% in the previous survey, based on a poll of 216 senior figures. The study found 74% of respondents were confident about increasing revenues, with 34% planning to upgrade existing systems and 24% intending to introduce new financial planning tools.
• Lincoln InternationalcoreStrategic or Co-development Partner · 11 May 2026Lincoln International and L.E.K. Consulting co-authored a comprehensive market analysis positioning healthcare logistics as a high-opportunity investment vertical, citing a market valued at approximately $140 billion in 2026 and expected to exceed $200 billion by 2030. The report highlights AI-enabled orchestration, cold-chain monitoring, and freight brokerage automation as key value creation vectors, while documenting accelerating M&A activity in the sector.
• ANDHealthcoreStrategic or Co-development Partner · 1 April 2026L.E.K. Consulting partnered with Australian digital health organization ANDHealth to support the sector's commercialization and real-world impact through in-kind strategic and analytical services. L.E.K.'s independent 2024 study found ANDHealth's accelerator program delivers strong returns, generating nearly $20 in capital raised and $4.20 in gross economic value per dollar invested, while creating 56 jobs per $1 million raised. The partnership aims to quantify outcomes and provide data-driven insights to help scale Australian evidence-based digital health technologies both nationally and internationally.
• The Discovery & Legal Technology Association (DLTA)minorStrategic or Co-development Partner · 11 February 2026The Discovery & Legal Technology Association released its inaugural eDiscovery: State of the Industry report developed in collaboration with L.E.K. Consulting, providing end-to-end insights on discovery workflows, AI adoption, and the expanding role of Alternative Legal Service Providers. The report highlights that ALSPs manage 500–550 petabytes of data while piloting and deploying nearly 100 AI tools across the EDRM in 2025.

Scale indicators10 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• McKinsey & Company: Global management consulting firm and the largest strategy advisor by revenue, with a comparable full-service strategy, M&A, and operations practice serving Fortune 500, PE, and public sector clients. Direct competitor for L.E.K.'s enterprise strategy engagements.
• Boston Consulting Group (BCG): Top-tier global strategy consulting firm with comparable capabilities in corporate strategy, M&A, pricing, performance improvement, and industry-specific practices. BCG's healthcare and life sciences practices overlap directly with L.E.K.'s strongest verticals.
• Bain & Company: Global strategy consulting firm with a particularly strong private equity practice and adjacent capabilities in performance improvement, M&A, and industry verticals. Bain's PE work overlaps directly with L.E.K.'s commercial due diligence franchise.
• Kearney (formerly A.T. Kearney): Closest scale-comparable peer: a global management consulting firm with similar size, footprint, and full-service strategy/operations offerings, including procurement and supply chain work that mirrors L.E.K.'s operations practice.
• Oliver Wyman: Global management consulting firm with strong practices in financial services, healthcare, and risk — overlapping directly with L.E.K.'s financial services and healthcare verticals. Comparable mid-large strategy firm competing for similar enterprise clients.
• Roland Berger: European-headquartered global strategy consulting firm of comparable size to L.E.K., with overlapping capabilities in corporate strategy, operations, and industry verticals. A direct competitor particularly in EMEA enterprise accounts.
• ZS Associates: Global consulting firm specializing in life sciences and healthcare strategy, sales, and marketing analytics. Direct competitor in L.E.K.'s most differentiated vertical (biopharma), particularly on commercial strategy, launch planning, and real-world evidence.

Broad incumbents

• EY-Parthenon: Strategy consulting arm of Big 4 firm EY offering transaction strategy, corporate strategy, and operational consulting. Competes with L.E.K. on PE due diligence and growth strategy, often with structural pricing advantages from the broader EY ecosystem.
• Strategy& (PwC): Strategy consulting arm of PwC, formed from the acquisition of Booz & Company, offering strategy, operations, and technology advisory. Comparable in scope to L.E.K. with a broader Big 4 platform for cross-sell.

Emerging players

• Putnam Associates: Boutique strategy consulting firm focused exclusively on life sciences and biopharmaceutical clients. Overlaps with L.E.K.'s Biomedical Intelligence Lab and Biopharma practice on indication prioritization, market access, and commercial strategy.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/l.e.k.-consulting
• Xx.com/lek_consulting
• Facebookfacebook.com/L.E.K.Consulting

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LEK Consulting